Brian Goff is the CEO of Agios Pharmaceuticals, appointed to the role in August 2022. He has a solid background in the pharmaceutical industry, previously serving as the Executive Vice President at Alexion Pharmaceuticals, where he led teams across various...
Brian Goff is the CEO of Agios Pharmaceuticals, appointed to the role in August 2022. He has a solid background in the pharmaceutical industry, previously serving as the Executive Vice President at Alexion Pharmaceuticals, where he led teams across various global markets. Brian holds an MBA from the prestigious Wharton School at the University of Pennsylvania, equipping him with a strong foundation in business management. Under his leadership, Agios focuses on reaching ambitious performance goals, and recently he earned a total compensation package of over $3.4 million, reflecting the company’s success and his impact. One interesting highlight is his impressive stock options and performance-based incentives that link his pay directly to the company’s achievements. Brian is known for being results-driven, emphasizing the importance of aligning executive compensation with the company's performance. Beyond numbers, he is focused on enhancing treatments for patients, showcasing his commitment to improving healthcare through innovation.